Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07081243 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Symplicity China Study

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Not Yet Recruiting to Recruiting Start date changed from estimate of Nov 4, 2025 to Nov 11, 2025v3 Show 1 more changeShow less
    • Start date changed from estimate of Nov 4, 2025 to Nov 11, 2025
  2. Start date: Jul 30, 2025 to Nov 4, 2025v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The Symplicity China study will evaluate the real-world long-term safety, efficacy, and durability of the Symplicity Spyral system in a population of approximately 500 renal denervation treated subjects with up to 36 months of follow up.
Trial Details
NCT Number NCT07081243
Lead Sponsor Medtronic Vascular
Conditions Resistant Hypertension
Enrollment 500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov